Abbott Labs To Buy Facet Biotech For $450M
Abbott Laboratories Inc. has said it will purchase Facet Biotech Inc. for $450 million as part of a plan to enhance its pharmaceutical pipeline and strengthen its business in immunology and...To view the full article, register now.
Already a subscriber? Click here to view full article